Additionally, high costs and limited insurance coverage, especially in developing markets, restrict access, underscoring the importance of improving affordability
I expect this setback to also drive #subcutaneous entrants to innovate further, such as developing longer-acting formulations or combo therapies to enhance patient convenience and adherence
Do peptides actually repair cartilage
This is huge compared to the 5 years of exclusivity for non-biologic drugs
Mentlein R, Gallwitz B, Schmidt WE (1993) Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(736)amide, peptide histidine methionine and is responsible for their degradation in human serum
We have pricing patterns from every GLP-1 medication launched since 2014, Eli Lilly's historical pricing strategy, and clear market dynamics